Home
>
National Drug Code (NDC)
>
TYSABRI
TYSABRI - 59075-730-15 - (natalizumab)
Drug Information of TYSABRI
| Product NDC: | 59075-730 |
| Proprietary Name: | TYSABRI |
| Non Proprietary Name: | natalizumab |
| Active Ingredient(s): | 300 mg/15mL & nbsp; natalizumab |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of TYSABRI
| Product NDC: | 59075-730 |
| Labeler Name: | Elan Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125104 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20041123 |
Package Information of TYSABRI
| Package NDC: | 59075-730-15 |
| Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (59075-730-15) > 1 mL in 1 VIAL, SINGLE-USE |
NDC Information of TYSABRI
| NDC Code | 59075-730-15 |
| Proprietary Name | TYSABRI |
| Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (59075-730-15) > 1 mL in 1 VIAL, SINGLE-USE |
| Product NDC | 59075-730 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | natalizumab |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20041123 |
| Marketing Category Name | BLA |
| Labeler Name | Elan Pharmaceuticals, Inc. |
| Substance Name | NATALIZUMAB |
| Strength Number | 300 |
| Strength Unit | mg/15mL |
| Pharmaceutical Classes | Integrin Receptor Antagonist [EPC],Integrin Receptor Antagonists [MoA] |
